GLOB

GLOB

USD

Globant S.A. Common Shares

$62.815+0.795 (1.282%)

实时价格

技术
Information Technology Services
卢森堡

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$62.020

最高价

$62.880

最低价

$60.675

成交量

1.00M

公司基本面

市值

2.8B

所属行业

Information Technology Services

国家/地区

Luxembourg

交易统计

平均成交量

1.58M

交易所

NYQ

货币

USD

52周价格范围

最低价 $54.36当前价 $62.815最高价 $238.32

相关新闻

PR Newswire

Globant to Announce Third Quarter 2025 Financial Results on November 13th

Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will...

查看更多
Globant to Announce Third Quarter 2025 Financial Results on November 13th
PR Newswire

Globant to Announce Third Quarter 2025 Financial Results on November 13th

Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will...

查看更多
Globant to Announce Third Quarter 2025 Financial Results on November 13th
Analyst Upgrades

Citigroup Initiates Coverage On Globant with Neutral Rating, Announces Price Target of $67

Citigroup analyst Bryan Keane initiates coverage on Globant with a Neutral rating and announces Price Target of $67.

查看更多
Citigroup Initiates Coverage On Globant with Neutral Rating, Announces Price Target of $67
Analyst Upgrades

Wells Fargo Initiates Coverage On Globant with Equal-Weight Rating, Announces Price Target of $61

Wells Fargo analyst Jason Kupferberg initiates coverage on Globant with a Equal-Weight rating and announces Price Target of $61.

查看更多
Wells Fargo Initiates Coverage On Globant with Equal-Weight Rating, Announces Price Target of $61
PR Newswire

MIT Technology Review Insights and Globant Report: Three quarters of global pharma organizations are piloting or deploying agentic AI

Globant (NYSE: GLOB), a digitally native company that helps organizations thrive in a digital and AI-powered future, has partnered with MIT...

查看更多
MIT Technology Review Insights and Globant Report: Three quarters of global pharma organizations are piloting or deploying agentic AI